Glaxosmithkline Consumer Healthcare Holdings (US) IP LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Glaxosmithkline Consumer Healthcare Holdings (US) IP LLC

Sort by

Viewing results 1‒25 of 107

FT CollectionsTech Exchange
Aidan Gomez: AI threat to human existence is ‘absurd’ distraction from real risks
...His line on it was: we were playing with a ChatGPT equivalent two years ago within Google and — for whatever reason — there was just this hesitation about putting it into consumers’ hands....
June 16, 2023
Illumina Inc
Illumina battle with regulators threatens cancer breakthrough, warn Grail alumni
...Grail is selling Galleri to US consumers for about $950 as a “laboratory-developed test”, a category that does not require approval from the US Food and Drug Administration and is not widely reimbursed by...
April 4, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
FT CollectionsTech Exchange
John Hanke: A real-world metaverse will be more magical than VR
...CC: Your games rely quite heavily on IP. Why do you think that this IP is key to gaming and AR gaming? JH: We do some original IP. Our first game, Ingress, was original....
October 3, 2022
Due Diligence
Adani empire rattled by cancelled share sale Premium content
...Its failed attempts to buy UK drugmaker GlaxoSmithKline’s consumer healthcare business, a politically fraught fight with Ben & Jerry’s and the arrival of the billionaire activist Nelson Peltz on Unilever...
February 2, 2023
#techFT
Palantir seeks blockbuster NHS deal Premium content
...Apple Pay Later will be serviced through a wholly owned subsidiary, Apple Financing LLC. Lex assesses the risks. 2....
June 9, 2022
Live news from January 17: Moderna chief says combined flu and Covid vaccine available in 2023, Yemen’s Houthi rebels strike UAE, China’s Xi defends ‘common prosperity’ reforms
GSK and Pfizer hold out for £60bn bid for consumer health unit
...GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer....
January 16, 2022
FT Live
US Decarbonization and Industrial Transition Summit
Securing the resources to build and finance America's clean energy future
Wednesday, 29 MayWashington, D.C., USA
Mergers & Acquisitions
GSK and Pfizer hold out for £60bn bid for consumer health unit
...GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer....
January 16, 2022
FT Asset Management
Howard Marks’ Oaktree steps in where others fear to tread Premium content
...Two of Unilever’s largest investors have called for radical shake-up of the company or its board in the wake of its abortive £50bn pursuit of GlaxoSmithKline’s consumer health business....
February 7, 2022
Due Diligence
Meet private equity’s king of SaaS Premium content
...Its attempted shake-up at Brentford-based healthcare group GlaxoSmithKline was blocked by the company’s board, which rejected Elliott’s demands to appoint new directors and re-evaluate whether chief executive...
December 8, 2021
Disrupted Times
IMF and World Bank highlight fragile state of global economy
...Huge recent payouts are all the more jarring because they come just as consumers face steep rises in the price of energy and food, writes US investment and industries editor Brooke Masters....
April 20, 2022
Due Diligence
Friends in high places: Buffett’s banker buys into Brunswick Premium content
...The consumer healthcare business, which owns brands such as Centrum vitamins and Sensodyne toothpaste, is a joint venture with Pfizer....
June 24, 2021
City Bulletin
Burberry makes ‘excellent start’ to its new trading year Premium content
...GlaxoSmithKline set out plans to build a new life sciences campus within its research and development site in Stevenage, funded by a £400m land sale....
July 16, 2021
City Bulletin
Suboxone maker Indivior overhauls board Premium content
...Also joining the board are Juliet Thompson, a former healthcare investment banker, former GlaxoSmithKline manager Jo Le Couiliard and Mark Stejbach, who used to be a director at rival drugmaker Alkermes....
March 24, 2021
News in-depthThe Big Read
Can we ever trust Google with our health data?
...This dual role of holding consumer and health data is already the subject of a lawsuit against Google and the University of Chicago....
January 20, 2020
News in-depthThe Big Read
Will the coronavirus crisis rehabilitate the banks?
...But he acknowledges the wider challenge: “What they’re doing on fiscal and monetary [policy] . . . is terrific, but the real thing that they have got to solve is the healthcare crisis.”...
April 1, 2020
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Inside BusinessRichard Waters
Privacy uproar shows Google cloud business has a trust problem
...But it also describes this week’s portrayal by the media of US healthcare provider Ascension’s decision to hand the records of 50m of its patients to Google....
November 15, 2019
#techFT
Google chief calls for AI regulation
...With its dual role of holding consumer and health data, there are concerns that it could mix the two and de-anonymise it....
January 20, 2020
News in-depthFTfm
Six charts that lay bare what went wrong for Woodford
...Mr Woodford appeared seduced by an increasing number of early-stage healthcare, technology and financial stocks....
November 16, 2019
Due Diligence
Elliott, Fortress and the tangle over a Japanese property developer Premium content
...Jagannath, who will focus on the healthcare and technology sectors, previously worked at The Carlyle Group....
August 22, 2019
Investments
Income-seeking investors face an uphill struggle
...Mining, commodities and healthcare stocks have also attracted attention....
April 24, 2020
FT Magazine
Why prescription drugs cost so much more in America
...But what they’re doing to Americans is price-gouging us and they are holding us hostage. And people are dying. People are being forced to go to emergency rooms. People are having their legs amputated....
September 19, 2019
Pfizer Inc
Pfizer and Mylan to combine off-patent drugs businesses
...Revenue from the biopharma division rose 2 per cent year on year but sales at Upjohn dropped 11 per cent while revenue from the consumer healthcare business was down 3 per cent....
July 29, 2019
Equities
Stocks to watch: Sainsbury’s, Pearson, Just Eat, GSK
...But both GSK’s HIV treatment division and its consumer healthcare arm were about 2 per cent weaker than hoped and Shingrix, its shingles vaccine, benefited from a rebate adjustment....
May 1, 2019
LombardMatthew Vincent
GSK boss was listening when impatient Woodford wanted break up
...and consumer healthcare divisions kept going unheeded....
December 19, 2018
European companies
Nestlé, Unilever and Coca-Cola bid for GSK’s Horlicks unit
...The vast majority of Horlicks sales come through the company’s Indian subsidiary, GlaxoSmithKline Consumer Healthcare, in which GSK has a 72.5 per cent holding....
September 18, 2018

Previous pagePage 1 of 5Next page